Description Retatrutide (LY3437943) is an investigational synthetic peptide compound developed for advanced research in metabolic science and receptor signaling pathways. It is a novel triple agonist that interacts with the GLP-1, GIP, and glucagon receptor pathways, making it a significant compound of interest in peptide and metabolic research. Retatrutide is studied for its molecular activity, receptor interactions, and potential role in understanding mechanisms related to energy metabolism, glucose regulation, and biological signaling. Its unique multi-receptor profile provides researchers with a valuable tool for investigating complex metabolic pathways and peptide-based approaches. This product is supplied as a research compound intended for laboratory and analytical applications only. It is not approved for human consumption, clinical use, or therapeutic applications.